Skip to main content

Advertisement

Table 2 Univariate and multivariate survival analysis of 265 APGC patients who underwentNo. 10/11 LNs removal (CR + SPR)

From: Risk evaluation of splenic hilar or splenic artery lymph node metastasis and survival analysis for patients with proximal gastric cancer after curative gastrectomy: a retrospective study

  Univariate analysis Multivariate analysis
5-year survival rate P RR 95%CI P
Gender
 Male 31.8%     
 Female 27.8% 0.564    
Age
  < 60 years 31.2%     
  ≥ 60 years 30.6% 0.843    
Tumor size
  < 5 cm 41.5%     
 5-10 cm 26.3%   1.467 1.049–2.051 0.025
  ≥ 10 cm 21.1% 0.001 1.515 0.969–2.369 0.069
Gastrectomy type
 Proximal 37.4%     
 Total 27.6% 0.047 1.008 0.731–1.391 0.961
pT stage
 pT2 71.4%     
 pT3 37.1%   1.399 0.657–2.980 0.384
 pT4a 23.6% < 0.001 1.860 0.904–3.826 0.092
pN stage
 pN0 51.5%     
 pN1 41.9%   0.983 0.589–1.642 0.949
 pN2 36.2%   1.048 0.648–1.694 0.849
 pN3 8.3% < 0.001 2.134 1.319–3.453 0.002
Bormann type
 Bor 1–2 43.4%     
 Bor 3–4 27.8% 0.007 1.142 0.766–1.704 0.515
Differentiation
 Well 36.0%     
 Poor 27.2% 0.025 1.164 0.862–1.572 0.323
Approach of lymphadenectomy
 SPR 36.3%     
 CR 27.0% 0.058    
NO.10/11 lymphnode
 Negative 40.2%     
 Positive 9.9% < 0.001 1.745 1.241–2.454 0.001
  1. CR: combination resectionof the stomach and spleen or spleen-co-pancreas; SPR: spleen-preserved NO.10/11 lymphadenectomy